CASTELLI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 1.196
EU - Europa 967
AS - Asia 740
SA - Sud America 197
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 19
OC - Oceania 1
Totale 3.193
Nazione #
US - Stati Uniti d'America 1.124
RU - Federazione Russa 519
CN - Cina 254
SG - Singapore 215
BR - Brasile 160
IT - Italia 141
SE - Svezia 117
VN - Vietnam 91
HK - Hong Kong 84
DE - Germania 54
FR - Francia 42
CA - Canada 36
BD - Bangladesh 27
FI - Finlandia 26
GB - Regno Unito 21
PL - Polonia 19
MX - Messico 17
IN - India 14
AR - Argentina 13
JP - Giappone 12
EC - Ecuador 10
ZA - Sudafrica 10
NL - Olanda 7
ES - Italia 6
TT - Trinidad e Tobago 6
CO - Colombia 5
TR - Turchia 5
CL - Cile 4
HN - Honduras 4
IE - Irlanda 4
IQ - Iraq 4
JO - Giordania 4
MY - Malesia 4
PH - Filippine 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
ID - Indonesia 3
JM - Giamaica 3
PK - Pakistan 3
UA - Ucraina 3
EG - Egitto 2
NP - Nepal 2
PY - Paraguay 2
RO - Romania 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BS - Bahamas 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
HR - Croazia 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MU - Mauritius 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.121
Città #
Dallas 239
Ashburn 149
Moscow 109
Singapore 106
Hong Kong 84
San Jose 78
Milan 67
Beijing 51
Shanghai 51
Ho Chi Minh City 37
New York 34
Council Bluffs 30
Hefei 30
Los Angeles 28
Lauterbourg 26
Princeton 24
Lawrence 23
Helsinki 19
São Paulo 19
Munich 17
Hanoi 16
Warsaw 16
Phoenix 15
Brescia 11
Atlanta 10
Santa Clara 10
Stockholm 10
Tokyo 10
Chennai 9
Falkenstein 9
Orem 9
Rome 9
Brooklyn 8
Chicago 8
Montreal 8
Frankfurt am Main 7
Mexico City 7
Toronto 7
Amsterdam 6
Cesano Boscone 6
Denver 6
Johannesburg 6
London 6
Naples 6
Nuremberg 6
San Francisco 6
Boston 5
Columbus 5
Poplar 5
Seattle 5
Bologna 4
Dublin 4
Guangzhou 4
Haiphong 4
Miami 4
Quito 4
The Dalles 4
Vancouver 4
Amman 3
Da Nang 3
Frankfurt Am Main 3
Guayaquil 3
Houston 3
Joinville 3
Kuala Lumpur 3
Lappeenranta 3
Manaus 3
Milwaukee 3
Passo Fundo 3
Salvador 3
Secaucus 3
Tashkent 3
The Bronx 3
Turku 3
Xi'an 3
Ancona 2
Ankara 2
Bandung 2
Barra Mansa 2
Betim 2
Birmingham 2
Boardman 2
Bogotá 2
Brasília 2
Buffalo 2
Calgary 2
Cape Town 2
Catania 2
Chaguanas 2
City of London 2
Como 2
Curitiba 2
Edmonton 2
Erbil 2
Ferraz de Vasconcelos 2
Florianópolis 2
Greensboro 2
Guarulhos 2
Jiaxing 2
Kassel 2
Totale 1.601
Nome #
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 240
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 206
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 151
A Biologically-validated HCV E1E2 Heterodimer Structural Model 139
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 137
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 136
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 136
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 125
Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets 118
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 114
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 105
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 103
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 102
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 101
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 97
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 92
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 88
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 88
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 85
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 84
Role and potential therapeutic use of antibodies against herpetic infections 83
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 82
Viral Respiratory Pathogens and Lung Injury 81
HCV E2 core structures and mAbs: something is still missing 80
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 76
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 71
Erratum: Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets (Nature Nanotechnology (2013) 8 (594-601)) 70
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 66
Salts drive controllable multilayered upright assembly of amyloid-like peptides at mica/water interface 66
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 64
miR-29a and miR-15b Modulate SARS-CoV-2 Beta and Omicron Infection in Human Lung Epithelial Cells 6
null 1
Totale 3.193
Categoria #
all - tutte 15.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 4 0 0 0 2 2 3 3 6
2022/2023186 57 45 25 1 1 27 10 11 7 0 2 0
2023/2024161 0 9 26 30 14 33 4 20 4 9 1 11
2024/2025451 45 11 6 19 20 51 82 79 49 28 32 29
2025/20261.942 153 171 271 254 164 56 122 135 445 68 49 54
2026/2027375 164 87 98 26 0 0 0 0 0 0 0 0
Totale 3.193